Islet β-cell failure in type 2 diabetes--Within the network of toxic lipids

Biochem Biophys Res Commun. 2015 May 8;460(3):491-6. doi: 10.1016/j.bbrc.2015.03.153. Epub 2015 Apr 3.

Abstract

Obesity-related type 2 diabetes develops in individuals with the onset of β-cell dysfunction. Pancreatic islet lipotoxicity is now recognized as a primary reason for the onset and progression of the disease. Such dysfunction is reflected by the aberrant secretory capacity and detrimental loss of β-cell mass and survival. Elevated circulating serum fatty acid levels and disordered lipid metabolism management are particularly interesting in the search for biologically relevant triggers of β-cell demise. Herein, we review various types of toxic lipid metabolites that may play a significant role in pancreatic islet failure. The lipotoxic effect on β-cells depends on the type of lipid mediator (e.g., long-chain fatty acids, diacylglycerols, ceramides, phospholipids), cellular location of its action (e.g., endoplasmic reticulum, mitochondria), and associated-organelle conditions (e.g., membranes, vesicles). We also discuss various aspects of lipid action in β-cells, including effects on metabolic pathways, stress responses (e.g., oxidative stress, endoplasmic reticulum stress, and autophagy), and gene expression.

Keywords: Autophagy; Endoplasmic reticulum stress; Fatty acid-induced toxicity; Mitochondrial dysfunction; Pancreatic β-cell; Type 2 diabetes mellitus.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Autophagy
  • Ceramides / metabolism
  • Diabetes Mellitus, Type 2 / physiopathology*
  • Endoplasmic Reticulum / metabolism
  • Endoplasmic Reticulum / physiology
  • Humans
  • Islets of Langerhans / physiopathology*
  • Mitochondria / physiology

Substances

  • Ceramides